We are live on ! Find out more
ICU icon

SeaStar Medical
ICU

48 hedge funds and large institutions have $98M invested in SeaStar Medical in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

2% more funds holding

Funds holding: 47 → 48 (+1)

0% more capital invested

Capital invested by funds: $97.9M → $98M (+$126K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.37% → 0.37% (-0%)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
YCM
Yakira Capital Management
Connecticut
+$2.06M
2
PC
Periscope Capital
Ontario, Canada
+$1.55M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$997K
4
WRBC
W.R. Berkley Corp
Connecticut
+$552K
5
LCM
Landscape Capital Management
New Jersey
+$10.2K

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$3.56M
2
Goldman Sachs
Goldman Sachs
New York
-$2.06M
3
Millennium Management
Millennium Management
New York
-$194K
4
GCL
Glazer Capital LLC
New York
-$169K
5
MC
Meteora Capital
Florida
-$138K
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
26
Gabelli Funds
New York
$627K – – –
CC
27
Centiva Capital
New York
$593K – – –
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
$577K – – –
CM
29
Crestline Management
Texas
$523K – – –
FTCM
30
First Trust Capital Management
Illinois
$467K – – –
TCM
31
Tenor Capital Management
New York
$411K – – –
Marshall Wace
32
Marshall Wace
United Kingdom
$401K – – –
CM
33
Cohanzick Management
New York
$355K – – –
AA
34
AQR Arbitrage
Connecticut
$313K – – –
HF
35
HRT Financial
New York
$298K -$2.56K -1 -0.9%
LCM
36
Landscape Capital Management
New Jersey
$280K +$10.2K +4 +4%
MTCM
37
Mint Tower Capital Management
Netherlands
$257K – – –
Millennium Management
38
Millennium Management
New York
$235K -$194K -76 -46%
KKRC
39
Kohlberg Kravis Roberts & Co
New York
$216K – – –
EPM
40
Equitec Proprietary Markets
Illinois
$206K – – –
GCL
41
Glazer Capital LLC
New York
$182K -$169K -66 -48%
DCM
42
Difesa Capital Management
New York
$163K – – –
RA
43
RiverPark Advisors
New York
$136K – – –
SSA
44
Schonfeld Strategic Advisors
New York
$109K – – –
Goldman Sachs
45
Goldman Sachs
New York
$104K -$2.06M -805 -95%
SOA
46
Sea Otter Advisors
Florida
$70K +$69K +27 New
UBS Group
47
UBS Group
Switzerland
$21K +$10.2K +4 +100%
TRCT
48
Tower Research Capital (TRC)
New York
$10K – – –
BFM
49
Boothbay Fund Management
New York
– -$3.56M -1,400 Closed
1
2

ICU Hedge Fund Activity: Q3 2022 in Review

48 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2022, worth a combined $98M — up 0.13% from $97.9M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ICU positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Yakira Capital Management, opening a new position worth an estimated $2.06M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $3.56M sold.

  • 48 institutional investors held SeaStar Medical (ICU) as of Q3 2022, up from 47 in Q2 2022.
  • Funds reported $98M of SeaStar Medical stock for Q3 2022, up 0.13% quarter-over-quarter.
  • 2 funds opened new SeaStar Medical positions in Q3 2022 and 1 closed out, a net change of +1 holder.
  • The largest SeaStar Medical buyer in Q3 2022 was Yakira Capital Management, an estimated $2.06M added.
  • The largest SeaStar Medical seller in Q3 2022 was Boothbay Fund Management, an estimated $3.56M sold.

Based on aggregated 13F filings for Q3 2022.